
The universal Reverse Transcriptase Core kit can be combined with each qPCR Core kit or qPCR MasterMix, available from Eurogentec. As the RT buffer and the PCR buffer are harmonized, optimal results will be obtained with this combination. The Reverse Transcriptase Core kit contains enough reagents for up to 300 / 500 - 10 µl reactions, using the EuroScript RT enzyme and the RNase Inhibitor. The kit contains a 10x buffer, dNTP mix, EuroScript, RNase Inhibitor and 25 mM MgCl2, oligo d(T) primers, random nonamers and RNase free water tubes.
Legal notices
FOR RESEARCH USE ONLY
NOTICE TO PURCHASER: LIMITED LICENSE
Authorized 5’ Nuclease Core Kit
This product is an Authorized 5’ Nuclease Core Kit. Use of this product is covered by one or more of the following US patents and corresponding patent claims outside the US: 5,079,352, 5,789,224, 5,618,711, 6,127,155, 5,677,152, 5,773,258, 5,407,800, 5,322,770, 5,310,652, 5,210,015, 5,487,972, and claims outside the US corresponding to US Patent No. 4,889,818. The purchase of this product includes a limited, non-transferable immunity from suit under the foregoing patent claims for using only this amount of product for the purchaser’s own internal research. Separate purchase of a Licensed Probe would convey rights under the applicable claims of US Patents Nos. 5,538,848, 5,723,591, 5,876,930, 6,030,787, 6,258,569, 5,804,375 (claims 1-12 only), and 6,214,979, and corresponding claims outside the United States. No right under any other patent claim and no right to perform commercial services of any kind, including without limitation reporting the results of purchaser’s activities for a fee or other commercial consideration, is conveyed expressly, by implication, or by estoppel. This product is for research use only. Diagnostic uses under Roche patents require a separate license from Roche. Further information on purchasing licenses may be obtained from the Director of Licensing, Applied Biosystems, 850 Lincoln Centre Drive, Foster City, California 94404, USA.
Licensed dsDNA-Binding Dye Research Kits
Use of this product is covered by one or more of the following US patents and corresponding patent claims outside the US:
5,079,352, 5,789,224, 5,618,711, 6,127,155, 5,677,152, 5,773,258, 5,407,800, 5,322,770, 5,310,652, 5,994,056, 6,171,785, and claims outside the US corresponding to US Patent No. 4,889,818. The purchase of this product includes a limited, non-transferable immunity from suit under the foregoing patent claims for using only this amount of product for the purchaser’s own internal research. No right under any other patent claim (such as apparatus or system claims in US Patent No. 6,814,934) and no right to perform commercial services of any kind, including without limitation reporting the results of purchaser’s activities for a fee or other commercial consideration, is conveyed expressly, by implication, or by estoppel. This product is for research use only. Diagnostic uses under Roche patents require a separate license from Roche. Further information on purchasing licenses may be obtained by contacting the Director of Licensing, Applied Biosystems, 850 Lincoln Centre Drive, Foster City, California 94404, USA.
Cyclic-substituted unsymmetrical cyanine dyes are covered by U.S. Patents 5,436,134 and 5,658,751 and licensed to Eurogentec S.A by Molecular Probes, Inc in the direct research field.
Use of UDG employs U.S. Patents 5,035,936, 5,945,313, 5,683,896 and their foreign counterparts licensed to Eurogentec, S.A from Invitrogen Corporation.